Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Bayer
< Previous
1
2
3
4
5
6
Next >
ESC 2024: Late-Breaking KERENDIA® (finerenone) Investigational Data Presented
September 01, 2024
From
Bayer
Via
Business Wire
ESC Congress 2024: Bayer to Present Phase III KERENDIA® (finerenone) Data
August 29, 2024
From
Bayer
Via
Business Wire
Bayer starts Phase III Trial in Non-Small Cell Lung Cancer (NSCLC)
August 29, 2024
From
Bayer
Via
Business Wire
Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-Coding RNAs (lncRNAs) in Oncology
August 28, 2024
From
Bayer
Via
Business Wire
Fast, Stable, Secure: New Bayer Hardware Simplifies Farm Activities, Equipment Setup and Provides Increased Value to Farmers
August 26, 2024
From
Bayer
Via
Business Wire
The Journal of American Medical Association (JAMA) publishes Elinzanetant Phase III data
August 22, 2024
From
Bayer
Via
Business Wire
Bayer Initiates Phase II Study of Soluble Guanylate Cyclase Activator (BAY3283142) in Patients With Chronic Kidney Disease
August 22, 2024
From
Bayer
Via
Business Wire
Bayer and Alara Imaging Announce Collaboration
August 05, 2024
From
Bayer
Via
Business Wire
Bayer Announces Primary Endpoint Achieved in Phase III FINEARTS-HF Cardiovascular Outcomes Study Investigating KERENDIA® (finerenone) in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction
August 05, 2024
From
Bayer
Via
Business Wire
Bayer Submits New Drug Application to U.S. FDA for Elinzanetant for the Treatment of Moderate to Severe Vasomotor Symptoms Associated With Menopause
August 01, 2024
From
Bayer
Via
Business Wire
Bayer announces positive topline results for NUBEQA® (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC)
July 17, 2024
From
Bayer
Via
Business Wire
Bayer and Kroger Team Up with Luke Bryan and Feeding America to Improve Access to Nutritious Food
July 13, 2024
From
Bayer
Via
Business Wire
One A Day® Launches Science-Backed Cellular Aging Support Supplement
July 09, 2024
From
Bayer
Via
Business Wire
Bayer and Rad AI Announce Collaboration agreement
June 27, 2024
From
Bayer
Via
Business Wire
Reality TV Couple Lauren Speed-Hamilton and Cameron Hamilton Help Daters Keep the FIZZ Alive with NEW Alka-Seltzer® Fizzy Melts
June 18, 2024
From
Bayer
Via
Business Wire
44 Members of Congress Call for Federal Screening Recommendations for Kidney Disease
June 05, 2024
From
Bayer
Via
Business Wire
Elinzanetant significantly reduces frequency and severity of moderate to severe hot flashes associated with menopause
May 16, 2024
From
Bayer
Via
Business Wire
Bayer presents latest data from oncology portfolio at 2024 ASCO Annual Meeting
May 16, 2024
From
Bayer
Via
Business Wire
Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
May 15, 2024
From
Bayer
Via
Business Wire
Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes and/or Heart Failure Shared at Heart Failure 2024 Congress
May 13, 2024
From
Bayer
Via
Business Wire
One A Day® Partners with Julian Edelman to Share #WellnessConfessionals
May 13, 2024
From
Bayer
Via
Business Wire
Bayer to Present Investigational Data from Comprehensive KERENDIA® (finerenone) Clinical Trial Program at Heart Failure 2024 Congress
May 10, 2024
From
Bayer
Via
Business Wire
WomenHeart and Bayer Join Forces to Enhance Heart Health Awareness and Education Among Women Across the U.S.
May 10, 2024
From
Bayer
Via
Business Wire
Midol® Addresses Period Education and Normalization of Menstrual Discomfort with PeriodTalk Initiative in Partnership with Nonprofit PERIOD.
May 09, 2024
From
Bayer
Via
Business Wire
Bayer to unveil late-breaking data from Phase III OASIS 1 and 2 for elinzanetant in the treatment of vasomotor symptoms associated with menopause
May 08, 2024
From
Bayer
Via
Business Wire
Bayer Introduces Iberogast™ in the U.S., Bringing Proven Plant-Based Relief to the Millions Who Experience Gut Health Issues
April 24, 2024
From
Bayer
Via
Business Wire
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
April 11, 2024
From
Bayer
Via
Business Wire
Bayer and Google Cloud to accelerate development of AI-powered healthcare applications for radiologists
April 09, 2024
From
Bayer
Via
Business Wire
Bayer’s Consumer Health Division Announces Changes to North America Leadership Team
April 09, 2024
From
Bayer
Via
Business Wire
Bayer Appoints Sue Ann Pentecost as Vice President, Head of U.S. Pharmaceutical Communications
April 01, 2024
From
Bayer
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.